Click for best price
Celiac Disease Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 563.4 million
|
Forecast Market size by 2030 |
US$ 1577.1 million
|
| Growth Rate |
CAGR of 15.7% |
Number of Pages |
108 Pages |
This research report provides a comprehensive analysis of the Celiac Disease Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Celiac Disease Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Celiac Disease Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Celiac Disease Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Celiac Disease Drugs market presents opportunities for various stakeholders, including Hospital Pharmacy, Retail Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Celiac Disease Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Celiac Disease Drugs market was valued at US$ 563.4 million in 2023 and is projected to reach US$ 1577.1 million by 2030, at a CAGR of 15.7% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Celiac Disease Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Celiac Disease Drugs market.
Market Overview: The report provides a comprehensive overview of the Celiac Disease Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., First Line of Treatment, Second Line of Treatment), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Celiac Disease Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Celiac Disease Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Celiac Disease Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Celiac Disease Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Celiac Disease Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Celiac Disease Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Celiac Disease Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Celiac Disease Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Celiac Disease Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
First Line of Treatment
Second Line of Treatment
Market segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Global Celiac Disease Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Celiac Disease Drugs, market overview.
Chapter 2: Global Celiac Disease Drugs market size in revenue.
Chapter 3: Detailed analysis of Celiac Disease Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Celiac Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Celiac Disease Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 563.4 million
|
| Forecast Market size by 2030 |
US$ 1577.1 million
|
| Growth Rate |
CAGR of 15.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
108 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Celiac Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Celiac Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Celiac Disease Drugs Overall Market Size
2.1 Global Celiac Disease Drugs Market Size: 2023 VS 2030
2.2 Global Celiac Disease Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Celiac Disease Drugs Players in Global Market
3.2 Top Global Celiac Disease Drugs Companies Ranked by Revenue
3.3 Global Celiac Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Celiac Disease Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Celiac Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Celiac Disease Drugs Players in Global Market
3.6.1 List of Global Tier 1 Celiac Disease Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Celiac Disease Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Celiac Disease Drugs Market Size Markets, 2023 & 2030
4.1.2 First Line of Treatment
4.1.3 Second Line of Treatment
4.2 By Type - Global Celiac Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Celiac Disease Drugs Revenue, 2019-2024
4.2.2 By Type - Global Celiac Disease Drugs Revenue, 2025-2030
4.2.3 By Type - Global Celiac Disease Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Celiac Disease Drugs Market Size, 2023 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Celiac Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Celiac Disease Drugs Revenue, 2019-2024
5.2.2 By Application - Global Celiac Disease Drugs Revenue, 2025-2030
5.2.3 By Application - Global Celiac Disease Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Celiac Disease Drugs Market Size, 2023 & 2030
6.2 By Region - Global Celiac Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Celiac Disease Drugs Revenue, 2019-2024
6.2.2 By Region - Global Celiac Disease Drugs Revenue, 2025-2030
6.2.3 By Region - Global Celiac Disease Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Celiac Disease Drugs Revenue, 2019-2030
6.3.2 US Celiac Disease Drugs Market Size, 2019-2030
6.3.3 Canada Celiac Disease Drugs Market Size, 2019-2030
6.3.4 Mexico Celiac Disease Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Celiac Disease Drugs Revenue, 2019-2030
6.4.2 Germany Celiac Disease Drugs Market Size, 2019-2030
6.4.3 France Celiac Disease Drugs Market Size, 2019-2030
6.4.4 U.K. Celiac Disease Drugs Market Size, 2019-2030
6.4.5 Italy Celiac Disease Drugs Market Size, 2019-2030
6.4.6 Russia Celiac Disease Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Celiac Disease Drugs Market Size, 2019-2030
6.4.8 Benelux Celiac Disease Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Celiac Disease Drugs Revenue, 2019-2030
6.5.2 China Celiac Disease Drugs Market Size, 2019-2030
6.5.3 Japan Celiac Disease Drugs Market Size, 2019-2030
6.5.4 South Korea Celiac Disease Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Celiac Disease Drugs Market Size, 2019-2030
6.5.6 India Celiac Disease Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Celiac Disease Drugs Revenue, 2019-2030
6.6.2 Brazil Celiac Disease Drugs Market Size, 2019-2030
6.6.3 Argentina Celiac Disease Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Celiac Disease Drugs Revenue, 2019-2030
6.7.2 Turkey Celiac Disease Drugs Market Size, 2019-2030
6.7.3 Israel Celiac Disease Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Celiac Disease Drugs Market Size, 2019-2030
6.7.5 UAE Celiac Disease Drugs Market Size, 2019-2030
7 Celiac Disease Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Celiac Disease Drugs Major Product Offerings
7.1.4 Roche Celiac Disease Drugs Revenue in Global Market (2019-2024)
7.1.5 Roche Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Celiac Disease Drugs Major Product Offerings
7.2.4 Merck Celiac Disease Drugs Revenue in Global Market (2019-2024)
7.2.5 Merck Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Celiac Disease Drugs Major Product Offerings
7.3.4 Johnson & Johnson Celiac Disease Drugs Revenue in Global Market (2019-2024)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 BiolineRx
7.4.1 BiolineRx Company Summary
7.4.2 BiolineRx Business Overview
7.4.3 BiolineRx Celiac Disease Drugs Major Product Offerings
7.4.4 BiolineRx Celiac Disease Drugs Revenue in Global Market (2019-2024)
7.4.5 BiolineRx Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Celiac Disease Drugs Major Product Offerings
7.5.4 Pfizer Celiac Disease Drugs Revenue in Global Market (2019-2024)
7.5.5 Pfizer Key News & Latest Developments
7.6 Innovate Biopharmaceuticals
7.6.1 Innovate Biopharmaceuticals Company Summary
7.6.2 Innovate Biopharmaceuticals Business Overview
7.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Major Product Offerings
7.6.4 Innovate Biopharmaceuticals Celiac Disease Drugs Revenue in Global Market (2019-2024)
7.6.5 Innovate Biopharmaceuticals Key News & Latest Developments
7.7 ImmusanT
7.7.1 ImmusanT Company Summary
7.7.2 ImmusanT Business Overview
7.7.3 ImmusanT Celiac Disease Drugs Major Product Offerings
7.7.4 ImmusanT Celiac Disease Drugs Revenue in Global Market (2019-2024)
7.7.5 ImmusanT Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Celiac Disease Drugs Major Product Offerings
7.8.4 Novartis Celiac Disease Drugs Revenue in Global Market (2019-2024)
7.8.5 Novartis Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Celiac Disease Drugs Major Product Offerings
7.9.4 Bristol-Myers Squibb Celiac Disease Drugs Revenue in Global Market (2019-2024)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Immunomedics
7.10.1 Immunomedics Company Summary
7.10.2 Immunomedics Business Overview
7.10.3 Immunomedics Celiac Disease Drugs Major Product Offerings
7.10.4 Immunomedics Celiac Disease Drugs Revenue in Global Market (2019-2024)
7.10.5 Immunomedics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Celiac Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Celiac Disease Drugs Market Drivers in Global Market
Table 3. Celiac Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Celiac Disease Drugs in Global Market
Table 5. Top Celiac Disease Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Celiac Disease Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Celiac Disease Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Celiac Disease Drugs Product Type
Table 9. List of Global Tier 1 Celiac Disease Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Celiac Disease Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Celiac Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Celiac Disease Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Celiac Disease Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Celiac Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Celiac Disease Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Celiac Disease Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Celiac Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Celiac Disease Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Celiac Disease Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Celiac Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Celiac Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Celiac Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Celiac Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Celiac Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Celiac Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Celiac Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Celiac Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Celiac Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Celiac Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Roche Company Summary
Table 31. Roche Celiac Disease Drugs Product Offerings
Table 32. Roche Celiac Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Roche Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Celiac Disease Drugs Product Offerings
Table 36. Merck Celiac Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Merck Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Celiac Disease Drugs Product Offerings
Table 40. Johnson & Johnson Celiac Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. BiolineRx Company Summary
Table 43. BiolineRx Celiac Disease Drugs Product Offerings
Table 44. BiolineRx Celiac Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. BiolineRx Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Celiac Disease Drugs Product Offerings
Table 48. Pfizer Celiac Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Pfizer Key News & Latest Developments
Table 50. Innovate Biopharmaceuticals Company Summary
Table 51. Innovate Biopharmaceuticals Celiac Disease Drugs Product Offerings
Table 52. Innovate Biopharmaceuticals Celiac Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Innovate Biopharmaceuticals Key News & Latest Developments
Table 54. ImmusanT Company Summary
Table 55. ImmusanT Celiac Disease Drugs Product Offerings
Table 56. ImmusanT Celiac Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. ImmusanT Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Celiac Disease Drugs Product Offerings
Table 60. Novartis Celiac Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Novartis Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Celiac Disease Drugs Product Offerings
Table 64. Bristol-Myers Squibb Celiac Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. Immunomedics Company Summary
Table 67. Immunomedics Celiac Disease Drugs Product Offerings
Table 68. Immunomedics Celiac Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 69. Immunomedics Key News & Latest Developments
List of Figures
Figure 1. Celiac Disease Drugs Segment by Type in 2023
Figure 2. Celiac Disease Drugs Segment by Application in 2023
Figure 3. Global Celiac Disease Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Celiac Disease Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Celiac Disease Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Celiac Disease Drugs Revenue in 2023
Figure 8. By Type - Global Celiac Disease Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Celiac Disease Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Celiac Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Celiac Disease Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Celiac Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Celiac Disease Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Celiac Disease Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Celiac Disease Drugs Revenue Market Share, 2019-2030
Figure 16. US Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Celiac Disease Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Celiac Disease Drugs Revenue Market Share, 2019-2030
Figure 28. China Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Celiac Disease Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Celiac Disease Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Celiac Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Roche Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Merck Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Johnson & Johnson Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. BiolineRx Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Pfizer Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Innovate Biopharmaceuticals Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. ImmusanT Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Novartis Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Bristol-Myers Squibb Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Immunomedics Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
